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SObjectives: Postoperative readmission affects patient care and healthcare costs. There is a paucity of nationwide
data describing the clinical significance of readmission after thoracic operations. The purpose of this study was
to evaluate the relationship between postoperative readmission and mortality after lung cancer resection.
Methods: Data were extracted for patients undergoing lung cancer resection from the linked Surveillance
Epidemiology and End Results–Medicare registry (2006-2011), including demographics, comorbidities, socio-
economic factors, readmission within 30 days from discharge, and 90-day mortality. Readmitting facility and
diagnoses were identified. A hierarchical regression model clustered at the hospital level identified predictors
of readmission.
Results: We identified 11,432 patients undergoing lung cancer resection discharged alive from 677 hospitals.
The median age was 74.5 years, and 52% of patients received an open lobectomy. Thirty-day readmission
rate was 12.8%, and 28.3% of readmissions were to facilities that did not perform the original operation.
Readmission was associated with a 6-fold increase in 90-day mortality (14.4% vs 2.5%, P<.001). The most
common readmitting diagnoses were respiratory insufficiency, pneumonia, pneumothorax, and cardiac compli-
cations. Patient factors associated with readmission included resection type; age; prior induction chemoradia-
tion; preoperative comorbidities, including congestive heart failure and chronic obstructive pulmonary
disease; and low regional population density.
Conclusions: Factors associated with early readmission after lung cancer resection include patient comorbid-
ities, type of operation, and socioeconomic factors. Metrics that only report readmissions to the operative
provider miss one-fourth of all cases. Readmitted patients have an increased risk of death and demandmaximum
attention and optimal care. (J Thorac Cardiovasc Surg 2014;148:2261-7)See related commentary on pages 2267-8.
GSupplemental material is available online.
Lung cancer is the leading cause of cancer death in the
United States,1 and resection remains the treatment of
choice for appropriate surgical candidates with early-stage
disease.2 Early postoperative readmission is not only clini-
cally relevant3 but also an important predictor of increased
resource use.4 Beginning in October of 2012, the Afford-
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The Journal of Thoracic and CarReduction Program, reducing Medicare payments for
excess readmissions for acute myocardial infarction, pneu-
monia, and heart failure.5 Because most early postoperative
readmissions are perceived as preventable, incentives to
reduce their occurrence are likely forthcoming in the future.
Currently, there is a paucity of national data describing
the frequency of postoperative readmissions after lung can-
cer resection. Data from the American College of Surgeons
National Surgical Quality Improvement Program report 30-
day readmission after all thoracic operations to be 11.9%,6
but further granularity is necessary to elaborate a pragmatic
quality metric. Although the development of a risk-adjusted
readmission metric for coronary artery bypass surgery is un-
der way through the Society of Thoracic Surgeons (STS),7
such a process is nonexistent for pulmonary resections. The
STS General Thoracic Surgery Database includes postoper-
ative outcomes up to 30 days for member providers, but
because the STS is composed primarily of thoracic surgery
specialists,8 the Surveillance Epidemiology and End
Results (SEER)-Medicare database may better represent
operative experiences nationwide.9
The primary objectives of this study were to determine
the frequency and associated risk factors of early readmis-
sion after lung cancer resection and to assess the impactdiovascular Surgery c Volume 148, Number 5 2261
Abbreviations and Acronyms
OR ¼ odds ratio
SEER ¼ Surveillance Epidemiology and End
Results
STS ¼ Society of Thoracic Surgeons
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Sof readmission on 90-day outcomes. We hypothesized that
readmission within 30 days of discharge is associated
with an increased risk of subsequent mortality.
METHODS
Surveillance Epidemiology and End
Results–Medicare Database
The SEER registry is a population-based collection of incident cases
and includes cancer diagnostic, descriptive, and therapeutic information
relevant to the time of diagnosis. The National Cancer Institute links the
SEER registry to Medicare data for eligible patients to provide comprehen-
sive information on survival, inpatient admissions, outpatient events, and
other healthcare claims for 93% of patients aged 65 years or more.10 These
data accurately account for postoperative readmissions and are not limited
to readmissions taking place at the facilities providing the index operation.
The combined SEER-Medicare database encompasses approximately 26%
of the population and provides an opportunity for longitudinal studies
broadly generalizable to the Medicare population.
Patient Selection
The 2006 to 2010 SEER-Medicare databasewas used to identify records
for all patients aged 66 years or more with non–small cell lung cancer of
any stage by American Joint Committee on Cancer criteria who received
surgical resection.11 Exclusionary criteria included enrollment in a Medi-
care Health Maintenance Organization, lung cancer diagnoses made at au-
topsy, prior lung cancer diagnoses within 1 year of index diagnosis, missing
date of diagnosis, wedge resection for stage IV disease, and death before
discharge from the operative admission. To ensure that all patients had
adequate presurgical records to identify comorbid diseases present at the
time of surgery, we also excluded patients who were not eligible for Medi-
care during the 3 months before surgery or who were diagnosed in 2006.
Demographic information available in the SEER-Medicare data
included age, gender, race, and the operative and readmitting facilities.
Clinical data included year of operation, final pathologic stage, procedure
type and approach, preoperative comorbidities, and readmission diagnoses.
To differentiate between readmissions for operative complications and un-
related readmissions, a panel of International Classification of Diseases,
Ninth Revision codes composed of respiratory, infectious, cardiac, wound,
and renal diagnoses werematched to readmission diagnoses recorded in the
SEER-Medicare database (Table E1). Comorbidities were identified using
the Deyo modification of the Charlson index12 and were defined using
criteria provided by the National Cancer Institute for use with diagnoses re-
ported within inpatient files (Medicare Provider Analysis and Review),
outpatient files (Outpatient Statistical Analysis File), and physician claims
data (National Claims History).13,14 Mortality measures were based on
Medicare death certificate records within the SEER-Medicare database.
The primary outcomes were readmission within 30 days of discharge
from the operative admission and mortality within 90 days of surgery.
Statistical Analyses
The mortality rate within 90 days of surgery was compared between the
readmitted and nonreadmitted patient groups. Subgroup analyses included2262 The Journal of Thoracic and Cardiovascular Surmortality rate comparisons based on the readmitting facility (operative vs
nonoperative) and readmitting diagnosis (operative complication vs unre-
lated). To compare mortality rates between patients who were readmitted
and patients who were not, a hierarchical generalized linear model for
90-day mortality using previously reported model predictors in addition
to 30-day readmission and restricted to patients who were discharged alive
was created.15 A single hierarchical generalized linear model was used to
estimate risk of readmission, with adjustments for data clustered by treat-
ment provider. Model predictors were selected a priori on the basis of liter-
ature review and frequency of occurrence within our dataset, and included
both clinical and socioeconomic risk factors. The statistical significance of
each predictor of readmission included in the models was assessed using
the F test statistic. A test for provider covariance was performed to deter-
mine whether risk-adjusted readmission rates varied significantly between
operative providers. All outcomes data were analyzed using SAS version
9.3 (SAS Institute, Inc, Cary, NC) and R version 3.0.2 statistical software.16
The University of Virginia Institutional Review Board for Health Sciences
Research approved this study.RESULTS
For patients diagnosed with non–small cell lung cancer be-
tween 2007 and 2009, SEER-Medicare captured 11,432 pa-
tients who were discharged alive after resection and who
met all inclusion criteria. The median age was 74.5 years at
the time of surgery, and most patients presented with stage I
disease (70.4%). Approximately half of patients were female
(51.5%), and the predominant race was white (89.7%). The
most common procedure performed was an open lobectomy
(51.6%), and thoracoscopic approaches accounted for
26.8% of resections (Table 1). The most common preopera-
tive comorbidities were chronic pulmonary disease, diabetes,
and peripheral vascular disease. Patients included within the
final study population were treated at 677 hospitals.
The overall readmission rate within 30 days of discharge
was 12.8% (1461/11,432), and 28.3% (414/1461) of read-
missions were to facilities that did not perform the index
operation. The median length of stay during postoperative
readmissions was 4 days (interquartile range, 2-7 days). Re-
admissions were more frequent within the first 2 weeks after
discharge (Figure 1). The mortality rate within 90 days of
surgery was approximately 6 times higher among patients
who experienced at least 1 early readmission (odds
ratio [OR], 6.6; 14.4% [210/1461] vs 2.5% [249/9971],
P< .001). Among readmitted patients, those who under-
went 2 or more readmissions within 60 days of discharge
did not have a significantly higher 90-day mortality rate
than those readmitted only once (16.2%, 58/358 vs
13.8%, 152/1103, P ¼ .295). In a hierarchical generalized
linear model for 90-day mortality, postoperative readmis-
sion within 30 days had the largest contribution to predict-
ing mortality risk (OR, 5.79; P<.001, F-test statistic 291).
The model C-statistic was 0.80 (Table 2).
Ninety-day mortality did not differ between patients who
were readmitted to the operative facility and patients who
were readmitted to an alternate facility (13.6% vs 16.4%,
P ¼ .16). However, of patients initially readmitted to agery c November 2014
TABLE 1. Patient demographics and preoperative comorbidities
Demographics n (%)
Age, y
65-69 2653 (23.2)
70-74 3437 (30.1)
75-79 3045 (26.6)
80-84 1751 (15.3)
85þ 546 (4.8)
Gender
Male 5545 (48.5)
Female 5887 (51.5)
Year of diagnosis
2007 3871 (33.9)
2008 3823 (33.4)
2009 3738 (32.7)
Race
White 10,252 (89.7)
Black 607 (5.3)
Asian 257 (2.3)
Hispanic 79 (0.7)
Other 229 (2.0)
Tumor stage
I 7906 (70.4)
II 1270 (11.3)
III 1682 (15.0)
IV 366 (3.3)
Not available 201 (1.8)
Operation
Open lobectomy/bilobectomy 5904 (51.6)
Open wedge resection 1244 (10.9)
Open segmentectomy 803 (7.0)
Open pneumonectomy 334 (2.9)
Chest wall resection with lung 88 (0.8)
VATS lobectomy 1625 (14.2)
VATS wedge resection 940 (8.2)
VATS segmentectomy 494 (4.3)
Comorbidities
Induction chemoradiation 563 (4.9)
Myocardial infarction 1172 (10.3)
Heart failure 1262 (11.0)
Peripheral vascular disease 1743 (15.2)
Cerebral vascular disease 1129 (9.9)
Chronic pulmonary disease 7078 (61.9)
Diabetes 3476 (30.4)
Chronic renal failure 1012 (8.9)
VATS, Video-assisted thoracoscopic surgery.
FIGURE 1. Time to readmission after discharge from lung cancer resec-
tion. Although early readmissions occur most frequently during the first 2
weeks after discharge, occurrences persist beyond 3 months.
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Snonoperative facility, 11.8% (49/414) were transferred
before discharge, compared with 0.86% of patients read-
mitted to the operative facility (9/1047, P<.001). Readmit-
ted patients whowere subsequently transferred had a higher
90-day mortality rate than those who were not (25.9%, 15/
58 vs 13.9%, 195/1403, P¼ .011), suggesting that transfers
of care were likely related to clinical acuity. On the basis of
primary admitting diagnoses, 54.1% (791/1461) of read-
missions were directly related to postoperative complica-
tions, the most common of which were respiratoryThe Journal of Thoracic and Carinsufficiency (24.0%, 190/791), pneumonia (16.7%, 132/
791), cardiac complications (14.8%, 117/791), and pneu-
mothorax (13.7%, 108/791) (Figure 2). Mortality at 90
days did not differ significantly between patients readmitted
because of operative complications and patients readmitted
with unrelated primary diagnoses (OR, 1.22; P ¼ .21).
Hierarchical generalized regression models were used to
estimate the risk of readmission within 30 days of
discharge. Hospital provider was included in the models
as a random effect, accounting for the clustering of proce-
dures within hospitals. The C-statistic for the predictive ac-
curacy of the model was 0.604. Predictors of early
readmission with the highest F-statistic in descending order
were chronic obstructive pulmonary disease, congestive
heart failure, prior induction chemoradiation, recent
myocardial infarction, and chronic renal failure (Table 3).
Of the procedure types evaluated, pneumonectomy and
combined lung and chest wall resection had the highest
ORs of early readmission. Of note, when compared with
video-assisted thoracoscopic surgery (VATS) wedge resec-
tions, more extensive VATS resections were associated with
a lower 30-day readmission rate. Among socioeconomic
factors, regional population density was associated with re-
admission, whereas regional high school nongraduation rate
trended toward an association. The test for provider covari-
ance was not significant (s2 ¼ 0.05, P ¼ .41), suggesting
that, after adjusting for clinical and socioeconomic risk fac-
tors, there was no evidence of significant differences in re-
admission rates across hospitals.DISCUSSION
The present study is the first to report the relationship be-
tween early readmission and postoperative mortality within
a national lung cancer resection database. Our resultsdiovascular Surgery c Volume 148, Number 5 2263
TABLE 2. Hierarchical regression for risk factors associated with
90-day mortality (model C-statistic: 0.80)
Variable OR CI P value F test
30-d readmission 5.79 4.73-7.09 <.001 290.7
Procedure type <.001 13.3
Pneumonectomy 3.97 2.41-6.56
Chest wall resection
with lung
6.18 3.08-12.4
Lobectomy/bilobectomy 1.06 0.72-1.55
Segmentectomy 1.50 0.92-2.43
Wedge resection 158 1.02-2.47
VATS lobectomy 0.74 0.46-1.18
VATS segmentectomy 0.62 0.31-1.26
VATS wedge resection Reference value
Surgical year .028 3.0
2007 0.60 0.36-0.99
2008 0.75 0.46-1.23
2009 0.87 0.53-1.40
2010 Reference value
Age, y .001 4.7
85þ 2.28 1.49-3.49
80-84 1.67 1.20-2.32
75-79 1.29 0.96-1.74
70-74 1.22 0.91-1.64
65-69 Reference value
Gender <.001 29.6
Female 0.56 0.46-0.69
Male Reference value
Race .263 1.3
Asian 0.39 0.14-1.07
Black 0.94 0.60-1.49
Other 0.75 0.39-1.47
White Reference value
Comorbidity
Induction chemoradiation 1.44 0.99-2.10 .055 3.7
Acute MI 0.85 0.62-1.17 .329 1.0
CHF 1.95 1.52-2.51 <.001 27.1
PVD 1.07 0.83-1.39 .604 0.3
Cerebrovascular disease 1.10 0.82-1.49 .532 0.4
COPD 1.27 1.02-1.58 .035 4.4
Diabetes 1.07 0.86-1.34 .532 0.4
Renal failure 1.15 0.86-1.56 .347 0.9
CHF, Congestive heart failure; CI, confidence interval; COPD, chronic obstructive
pulmonary disease; MI, myocardial infarction; OR, odds ratio; PVD, peripheral
vascular disease; VATS, video-assisted thoracoscopic surgery.
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common and substantially underestimated by metrics that
only report readmissions to the operative facility. Even
more important, early readmission after lung cancer resec-
tion is associated with a 6-fold increase in the risk of death.
Our results highlight the acuity of patients readmitted after
lung resections and argue for intensified resource allocation
and clinical awareness. When presented with these patients,
clinicians should maintain a low threshold for admission to
intensive care units and transfer to tertiary care centers.2264 The Journal of Thoracic and Cardiovascular SurOur study using SEER-Medicare data encompasses a
large, diverse group of hospitals. Within this group, overall
30-day readmission rate after lung cancer resection was
12.8%. This finding is in concordance with outcomes
derived from 1992-2002 SEER-Medicare data showing a
15% 30-day readmission rate,4 suggesting that risk of post-
operative readmission in this population has not changed
significantly over the last 15 years. Freeman and col-
leagues17 recently reported a 7% operation-related,
90-day readmission rate and an 8.3% overall readmission
rate within a high-volume, multi-institutional database.
Likewise, Varela and colleagues18 reported an emergency
30-day readmission rate of 6.9%. Within our dataset, a
higher overall readmission rate may be related in part to
the older median age of the Medicare population; this is re-
flected by the high rate of readmissions that were unrelated
to the index operation (45.9%). Isolating readmissions
related to postoperative complications revealed an occur-
rence rate of 6.9%, which is in concordance with prior
studies. A higher rate of readmissions unrelated to the index
operation within our dataset also may be due to inclusion of
more low-volume centers in areas with less abundant outpa-
tient resources. However, testing for provider covariance
within our dataset showed that risk-adjusted readmission
rates did not differ significantly between hospitals. This
finding likely reflects the wide range of provider case vol-
umes, which greatly reduces the utility of readmission
rate as a differentiating quality metric.
Our analyses demonstrate that 30-day readmission after
lung cancer resection is the strongest risk factor for 90-
day mortality, outperforming all commonly reported
preoperative predictors. Furthermore, this association was
independent of the readmitting facility (operative vs
nonoperative) and the readmission category (operative
complication vs unrelated). Readmitted patients who were
transferred to another facility had a higher 90-day mortality
rate than those whowere not. Rather than suggesting a caus-
ative effect, we believe this association is reflective of the
appropriate transfer of high-acuity patients to tertiary care
facilities. Single- and multi-institutional data have shown
a significant decrease in long-term survival among patients
who underwent lung resection and had early readmis-
sion.4,19 Our results indicate that this effect is even more
critical over the initial months after surgery. Although
mortality 2 to 5 years after resection may not be regarded
as surgically related or preventable, death within 90 days
from surgery is more likely to be attributable to the
perioperative experience and may offer opportunities for
early intervention.
Hierarchical regression demonstrated that socioeco-
nomic factors, such as regional high school nongraduation
rate and population density, may be related to the likelihood
of postoperative readmission. A recent study within the
cardiac surgery community also identified lower educationgery c November 2014
FIGURE 2. Distribution of primary readmitting diagnoses over time. Operative complications comprised 54.1% (791/1461) of all readmissions (left).
Among pulmonary operative complications, the most common readmitting diagnoses were respiratory insufficiency, pneumonia, and pneumothorax (right).
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readmission.20 Although similar results in general thoracic
surgery have borne out in a multi-institutional European
study relating regional deprivation scores to readmission,21
a link between socioeconomic factors and readmission
after lung resection has not been demonstrated in the
United States. Because of protocols protecting patient
confidentiality, a direct analysis of participant census data
is not available through SEER-Medicare; thus, socioeco-
nomic surrogate covariates were chosen. The association
between regional socioeconomic factors and risk of
readmission highlights some of the difficulties with patient
education and outpatient care access, and advocates
for further development of healthcare infrastructure in
disadvantaged regions.
Among preexisting clinical risk factors, chronic obstruc-
tive pulmonary disease, congestive heart failure, induction
chemoradiation, recent myocardial infarction, renal failure,
and age were all significantly associated with rate of read-
mission. Not surprisingly, pneumonectomy was the opera-
tion associated with the highest risk of postoperative
readmission. These results are in concordance with most
published series4,17,19,21 and expand on existing evidence
through using a large national database and implementing
a hierarchical multiple regression model that adjusts for
the provider. Awareness of the most important comorbid
risk factors may assist with postoperative management
and discharge planning. Among patients who are at high
risk for readmission, early postdischarge telephone calls
to assess pain control, home oxygen requirements, and
adequate performance of activities of daily living may be
a simple and inexpensive means to reduce the likelihood
of unnecessary readmission.22 Such a protocol may allow
early identification of warning signs to promote proactive
intervention when indicated. Our finding that more exten-
sive VATS resections are associated with a reducedThe Journal of Thoracic and Carreadmission rate compared with VATS wedge resections
may be reflective of the fact that more extensive resections
tend to be performed in patients with better preoperative
functional reserve.23 Of note, VATS resections constituted
only 26.7% of the lung resections within our dataset. Mini-
mally invasive procedures may comprise a higher propor-
tion of the operative volume within specialized thoracic
centers, such as those represented by the STS General
Thoracic Surgery Database.24 The frequency and predictors
of postoperative readmissions in this setting deserve further
focused study.
Study Limitations
First, the SEER-Medicare database excludes patients
aged less than 65 years. Thus, the median age of our dataset
is older than the general population undergoing lung cancer
resection and may lend selection bias to both the rate of re-
admission and the rate of 90-day mortality. However, the
median age of patients included in this study is only slightly
more than the median age at diagnosis for non–small cell
lung cancer nationally (70 years).25 Furthermore, the
average age of patients undergoing lung cancer resection
included in the STS database is 67 years, which falls within
the Medicare population.24 Second, despite accounting for
17 variables, our hierarchical model for early readmission
achieved a C-statistic of only 0.604, indicating that the
model had only modest ability to predict future readmis-
sions. Because of the presence of many interrelated and
often immeasurable factors that contribute to postoperative
readmissions, this outcome has historically been difficult to
predict.26 For example, an existing 18-variable readmission
model used in a large, single-institution study of patients
undergoing cardiac surgery had a C-statistic of only 0.7.27
Likewise, subspecialty-specific American College of Sur-
geons National Surgical Quality Improvement Program
prediction models for readmission also perform modestly,diovascular Surgery c Volume 148, Number 5 2265
TABLE 3. Clinical risk factors for 30 day readmission (model
C-statistic: 0.604)
Variable OR CI P value F test
Procedure type .018 2.4
Pneumonectomy 1.21 0.85-1.72
Chest wall resection with
lung
1.15 0.62-2.13
Lobectomy/bilobectomy 0.82 0.66-1.01
Segmentectomy 0.96 0.72-1.27
Wedge resection 0.78 0.60-1.01
VATS lobectomy 0.74 0.58-0.95
VATS segmentectomy 0.69 0.49-0.98
VATS wedge resection Reference value
Surgical year .584 0.7
2007 1.08 0.78-1.49
2008 1.17 0.85-1.61
2009 1.14 0.83-1.57
2010 Reference value
Age, y .025 2.8
85þ 1.47 1.11-1.94
80-84 1.22 1.00-1.48
75-79 1.21 1.03-1.44
70-74 1.07 0.91-1.26
65-69 Reference value
Gender .049 3.9
Female 0.88 0.78-1.00
Male Reference value
Race .190 1.6
Asian 0.80 0.52-1.24
Black 0.75 0.57-1.01
Other 0.88 0.60-1.28
White Reference value
Comorbidity
Induction chemoradiation 1.52 1.19-1.93 <.001 11.5
Acute myocardial
infarction
1.25 1.01-1.50 .015 5.9
Congestive heart failure 1.56 1.32-1.83 <.001 27.9
Peripheral vascular
disease
1.14 0.98-1.34 .093 2.8
Cerebrovascular disease 1.18 0.99-1.42 .070 3.3
COPD 1.47 1.29-1.67 <.001 34.3
Diabetes 1.15 1.01-1.31 .035 4.5
Renal failure 1.25 1.04-1.51 .018 5.6
Married 0.96 0.85-1.09 .530 0.4
Regional median income .570 0.7
Q1 (lowest income) 0.89 0.67-1.18
Q2 0.95 0.74-1.22
Q3 1.06 0.85-1.32
Q4 1.05 0.86-1.29
Q5 (highest income) Reference value
Regional population density .032 2.7
Q1 (least dense) 0.92 0.75-1.13
Q2 1.15 0.95-1.39
Q3 1.14 0.94-1.38
Q4 1.24 1.03-1.50
Q5 (most dense) Reference value
.067 2.2
(Continued)
TABLE 3. Continued
Variable OR CI P value F test
Regional high school
nongraduation
Q1 (fewest nongraduates) 0.79 0.60-1.03
Q2 0.73 0.57-0.93
Q3 0.91 0.73-1.13
Q4 0.97 0.79-1.18
Q5 (most nongraduates) Reference value
CI, Confidence interval; COPD, chronic obstructive pulmonary disease; OR, odds ra-
tio; Q, quintile; VATS, video-assisted thoracic surgery.
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rating a number of relevant perioperative clinical data.6
Because the SEER-Medicare database does not enable sep-
aration between preoperative and postoperative diagnosis
codes within index operative admissions, we were unable
to reliably account for postoperative complications within
our predictive models. The moderate C-statistic notwith-
standing, the present hierarchical multivariate regression
model augments existing univariate analyses within the
thoracic literature and highlights preoperative factors that
warrant increased awareness of readmission risk.CONCLUSIONS
Readmissions within 30 days of discharge after lung can-
cer resection are common and underestimated by metrics
that focus only on the operating facility. Factors that
increase the risk of readmission include preoperative co-
morbidities, procedure type, and socioeconomic factors.
Although accurately predicting a future readmission in the
preoperative setting is difficult, consideration of relevant
risk factors should be a requisite component of discharge
planning. Most important, patients who present with an
early readmission are at high risk of subsequent death and
demand maximum attention and care.References
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SThe crisis of readmissions: Symptom or disease?Varun Puri, MD, MSCIUnexpected readmission after major lung resection is a rela-
tively common occurrence and a major financial burden to
the health care system. Although no clear data on lung cancer
surgery are available, the Center for Medicare and MedicaidServices estimates its annual costs for 30-day readmission to
hospitals to be $26 billion.1 As Hu and colleagues have
shown in their article in this issue of the Journal, the overall
long-term burden to society goes well beyond direct costs,
because readmissions are associated with a significantly
elevated risk of 90-day mortality. As part of the Affordable
Care Act’s Hospital Readmissions Reduction Program, pub-
lic reporting of readmission rates has now been mandated,
with potential financial penalties for institutions with exces-
sive readmissions. Thus without a doubt preventing and
appropriately managing readmissions in thoracic surgery is
not only a medical necessity but a financial imperative for
programs. This is especially true because competing nonop-
erative techniques for treating lung cancer are almost entirely
free from the burden of readmissions.
Hu and colleagues, as well as previous authors, have
treated readmission both as an important outcome variable
in and of itself and as a predictor variable for further
downstream events (death, disability, etc). For statisticaldiovascular Surgery c Volume 148, Number 5 2267
TABLE E1. International Classification of Diseases, Ninth Revision diagnosis codes for relevant postoperative complications
Complication category ICD-9 diagnosis codes
Lung cancer* 162.2 162.3 162.4 162.5 162.8 162.9 197.2 196.1
Respiratory insufficiency
COPD 491.21 491.22 492 496
Aspiration 507 507.0 507.8 508.8 508.9
Dyspnea 786.0
Other 518.5 518.81 518.84 997.3 997.31 997.39
Cardiac complications
Myocardial infarction 410-410.99
Cor pulmonale 415.0
Dysrhythmias 427.0 427.3 427.4 427.5 427.89 427.9
Heart failure 428.0 428.1 428.2 428.21 428.23 428.3 428.31 428.33 428.4
428.41 428.43 428.9
Other 997.1 785.51 997.1 998.01
Pneumonia 481 482 483.8 486 513.0 997.32
Pneumothorax 512 998.81
Effusion/empyema 510 511.1 511.8 511.9
Pulmonary embolism 415.1 415.12 415.13 415.19
Acute kidney injury 584 586 276.5
Wound complications 875 998.3 998.83
Other postoperative infections
Cystitis 595.0 599.0 788.1
Cellulitis 682.2 686.8 686.9
Other 998.5
COPD, Chronic obstructive pulmonary disease; ICD-9, International Classification of Diseases, Ninth Revision. *For readmissions with a primary readmitting diagnoses of lung
cancer, the second readmitting diagnosis was used.
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